Stockscreener 앱 받기
2.07
3.27%
-0.07
전일 마감가:
$2.14
열려 있는:
$2.11
하루 거래량:
140.47K
Relative Volume:
0.91
시가총액:
$19.54M
수익:
$14.58M
순이익/손실:
$-12.57M
주가수익비율:
-0.3644
EPS:
-5.68
순현금흐름:
$-13.07M
1주 성능:
+0.49%
1개월 성능:
+2.48%
6개월 성능:
-65.90%
1년 성능:
-65.21%
1일 변동 폭
$2.00
$2.15
1주일 범위
$1.94
$2.18
52주 변동 폭
$1.925
$7.95
비보스 테라퓨틱스 Stock (VVOS) Company Profile
명칭
Vivos Therapeutics Inc
전화
(866)908-4867
주소
7921 SOUTHPARK PLAZA,, LITTLETON
VVOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
2.07 | 20.20M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
비보스 테라퓨틱스 주식(VVOS)의 최신 뉴스
Vivos Therapeutics announces $4.64 million warrant exercise deal By Investing.com - Investing.com Nigeria
Vivos Therapeutics Secures Convertible Bridge Financing Facility - TipRanks
Vivos Therapeutics Signs Convertible Note Agreement With V-Co Investors 3 - TradingView — Track All Markets
Vivos Therapeutics announces $4.64 million warrant exercise deal - Investing.com India
Vivos Therapeutics (VVOS) Exercises Warrants for $4.64M in Funding - Intellectia AI
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos secures $4.64M from warrant exercise - Stock Titan
Dividend Watch: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Earnings Recap & Weekly Momentum Picks - baoquankhu1.vn
Aug Summary: Is Vivos Therapeutics Inc part of any ETF2025 EndofYear Setup & Real-Time Volume Spike Alerts - baoquankhu1.vn
Earnings Risk: Will Allogene Therapeutics Inc stock hit new highs in YEARJobs Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Alliance Global Partners Sticks to Its Hold Rating for Vivos Therapeutics (VVOS) - The Globe and Mail
Is Vivos Therapeutics Inc. stock a safe buy before earningsWeekly Stock Report & Long Hold Capital Preservation Tips - Улправда
Is Vivos Therapeutics Inc. stock a buy in volatile markets2025 Price Momentum & Weekly Stock Breakout Alerts - ulpravda.ru
Why analysts remain bullish on Vivos Therapeutics Inc. stockJuly 2025 Review & Safe Swing Trade Setup Alerts - Улправда
Can Vivos Therapeutics Inc. stock weather global recessionJuly 2025 Patterns & Growth Oriented Trade Recommendations - Улправда
Published on: 2026-01-08 23:11:17 - Улправда
Aug Update: Can Vivos Therapeutics Inc. stock weather global recessionPortfolio Profit Report & Fast Gaining Stock Reports - Улправда
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
How Vivos Therapeutics Inc. stock compares to industry benchmarksUtilities Sector Analysis & See Risk Factors Before Making Any Move - Улправда
Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Is Vivos Therapeutics Inc a good long term investmentProtective Put Strategies & Ride the Trends That Billionaires Follow - earlytimes.in
Vivos Therapeutics (NASDAQ:VVOS) Trading Up 24.6% – What’s Next? - Defense World
Aug Breakouts: Why retail investors favor Vivos Therapeutics Inc stock2025 AllTime Highs & Capital Protection Trade Alerts - moha.gov.vn
VVOS SEC FilingsVivos Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Vivos Inc Summarizes Progress in its Animal Therapy Division - GlobeNewswire
Cancer-fighting pet therapy soars 1,200% as more vets join in 2025 - Stock Titan
A new cancer treatment for pets is quietly spreading across U.S. clinics - Stock Titan
Buyout Rumor: What dividend safety score for Vivos Therapeutics Inc. stockFed Meeting & Free Fast Entry Momentum Trade Alerts - Улправда
Will Vivos Therapeutics Inc. stock see insider buyingRecession Risk & Safe Capital Growth Trade Ideas - Улправда
ETF Watch: What dividend safety score for Vivos Therapeutics Inc. stockJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - Улправда
Is Vivos Therapeutics Inc. stock a safe investment in uncertain marketsPortfolio Risk Summary & Low Risk Investment Opportunities - DonanımHaber
Why Vivos Therapeutics Inc. stock is popular among millennialsWeekly Profit Summary & Stepwise Trade Signal Guides - Bölüm Sonu Canavarı
Published on: 2025-12-19 13:18:12 - DonanımHaber
Stop Loss: How Vivos Therapeutics Inc. stock compares to industry benchmarksAnalyst Upgrade & Free Weekly Chart Analysis and Trade Guides - Улправда
Vivos Therapeutics Opens Affiliated Sleep Center in Michigan - Sleep Review
Vivos Therapeutics, Inc. Announces Grand Opening of Sleep Center in Michigan - TradingView — Track All Markets
Vivos opens new sleep center in Michigan, expanding national footprint By Investing.com - Investing.com Nigeria
Vivos opens new sleep center in Michigan, expanding national footprint - Investing.com India
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan - The Manila Times
Vivos Therapeutics (NASDAQ: VVOS) expands with MISleep-linked Detroit sleep center - Stock Titan
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST - The Manila Times
Vivos Therapeutics, Inc. CEO and CFO Set to Discuss Strategic Business Model and Market Opportunities in Upcoming Fireside Chat - Quiver Quantitative
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST - GlobeNewswire Inc.
Vivos Therapeutics (NASDAQ: VVOS) to discuss strategy in Water Tower fireside chat - Stock Titan
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Vivos Therapeutics Inc Stock Analysis and ForecastBull Market Opportunities & Use Our Sector Rotation Strategy for Gains - earlytimes.in
What analysts say about Vivos Therapeutics Inc stockPrice Momentum Alerts & What the Pros Are Saying About This Stock - earlytimes.in
Vivos Therapeutics secures $2M note with Avondale - MSN
Vivos Therapeutics Secures $2M Note with Avondale - The Globe and Mail
Vivos Therapeutics, Inc. Enters into a Note Purchase Agreement with Avondale Capital, LLC - marketscreener.com
Can Vivos Therapeutics Inc. stock beat analyst upgradesJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser
비보스 테라퓨틱스 (VVOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):